Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 2 out of 15 pages
Exam (elaborations)

NR 546 Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner MidTerm Exam Test 2026: 90+ Questions & verified Answers | Graded A+ | Guaranteed Pass!!

Document preview thumbnail
Preview 2 out of 15 pages

CONQUER YOUR NR 546 MIDTERM WITH 100% VERIFIED ANSWERS! GUARANTEED A+! Stop stressing and start passing! This comprehensive study guide contains 95 meticulously curated questions with the correct answers clearly identified, covering every critical topic you'll face on the NR 546 Psychopharmacology midterm. It's your ultimate shortcut to mastering the material and securing a top grade. This isn't just a random collection of questions—it's a strategic review of the most heavily tested concepts that professors love to include on exams. Here's what you'll master: Neuroanatomy & Brain Function: Know exactly which lobe controls movement and intelligence (Frontal Lobe), which region handles speech comprehension (Wernicke's Area), and the role of the hippocampus in memory and anxiety. Understand what happens when specific brain areas are damaged. Neurotransmitters & Pathways: Get crystal clear on dopamine's role in Parkinson's and schizophrenia, the "happy hormone" (serotonin/5HT), GABA as the chief inhibitory neurotransmitter, and the four major NTM categories. Plus, master the mesolimbic, mesocortical, and tuberoinfundibular pathways—and exactly which symptoms and side effects they're associated with (positive symptoms, hyperprolactinemia, etc.). Antipsychotics—FGA vs. SGA: Learn the difference between first-generation (typical) and second-generation (atypical) antipsychotics. Know which medications carry the highest risk for hyperprolactinemia and galactorrhea (Risperidone), which is best for insomnia and is the best-tolerated antipsychotic (Olanzapine), and which requires monitoring for rash (Ziprasidone/Geodon). Understand EPS, tardive dyskinesia, akathisia, dystonia, and neuroleptic malignant syndrome inside and out. Pharmacokinetics & Pharmacodynamics: Master the critical concepts of agonists, partial agonists, inverse agonists, and antagonists. Understand the difference between a CYP450 inducer and inhibitor, and know the classic examples of each (e.g., amiodarone, sulfonamides = inhibitors; carbamazepine, rifampin, alcohol = inducers). Learn how smoking affects antipsychotic metabolism and why grapefruit juice is a danger. Clinical Decision-Making: This guide teaches you how to apply pharmacology to real patient scenarios. Learn how to adjust doses based on smoking status, manage drug interactions (like amiodarone and olanzapine), interpret pharmacogenomic testing, recognize SSRI discontinuation syndrome (and why fluoxetine is the solution), and understand when to draw an ammonia level for a patient on valproic acid. Why this is your #1 study tool: Each question is designed to test your clinical reasoning, and every answer is verified and graded A+. This guide transforms complex pharmacology into simple, memorable facts. You'll learn not just what the answer is, but why it's correct, building the deep understanding you need to ace the exam and excel in clinical practice. Don't gamble with your grades. This is the fastest, most efficient way to prepare for the NR 546 midterm. Invest in your success and guarantee your pass!

Content preview

NR 546 MIDTERM EXAM TEST 2026: 90+ QUESTIONS AND 100% VERIFIED
ANSWERS | GRADED A+ | GUARANTEED PASS!!

1. Which of the following data is most accurate in determining a treatment plan for a
patient who presents with depression? ANS: The patient states that they are experiencing
feelings of sadness, insomnia, and lack of appetite

2. Informed Consent ANS: clients have the right to receive enough information to
make decisions about their treatment. They must also be informed about the potential
risks associated with medication. Clients have the right to refuse treatment and cannot
be forcibly medicated in non-emergencies.


3. Which lobe is responsible for movement and intelligence and can result in
personality changes if damaged? ANS: Frontal Lobe

4. The PMHNP wants to prescribe olanzipine for a client with depression. However, the
client currently takes amiodarone for chronic atrial fibrillation. What does the PMHNP
need to do to establish efficiency of this medication? ANS: Decrease the dosage of
olanzipine

Amiodarone is a CYP450 inhibitor which means it will stop/slow down the olanzapine from
metabolizing in the body.
Therefore, the olanzapine is at risk for building up in the client's system rather than being
metabolized and secreted.


5. What NTM is responsible for a patient's diagnosis of Parkinson's? ANS: Dopamine

dopamine affects balance and coordination, low levels are found in Parkinson's.

6. A surgical patient is post-op after a hernia repair. The patient is given opioids in the
OR and now has a shallow respiratory rate, pinpoint pupils, and is unresponsive to verbal


, stimulation. The PMHNP prescribed naloxone to reverse the effects of the opioids. Where
does Naloxone fall on the agonist spectrum? ANS: Antagonist

7. Medications for schizophrenia target which main neurotransmitter? ANS:
Dopamine

dopamine causes negative and positive symptoms of schizophrenia, medication block
dopamine to reduce these symptoms


8. first generation antipsychotics improve _________ symptoms, and there is a higher
risk of developing _________. ANS: positive, hyperprolactinemia
9. Which medication is a good option for a patient with schizophrenia who also suffers
from insomnia? ANS: Olanzapine
Olanzapine is the best tolerated antipsychotic


10. What brain region is responsible for speech comprehension? ANS: Wernicke's Area

11. Which neurotransmitter may be responsible for a client's symptoms of depression?
SATA
a. increased level of ACH
b. decreased levels of NE
c. increased levels of 5HT
d. decreased levels of histamine
e. increased levels of glutamate ANS: a. increased levels of ACH b. decreased levels of NE
d. decreased levels of histamine


12. Which pathway is associated with hyperprolactemia? ANS: Tuberoinfundibular

13. True or False: Sulfonamides are an example of CYP450 inducer. ANS: False, they are
inhibitors

Document information

Uploaded on
July 31, 2026
Number of pages
15
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$13.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
MYNET
3.8
(44)
Sold
228
Followers
16
Items
1608
Last sold
1 day ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions